The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday ...
The approval marks the second for a generic in this class of medications ... an 18 mg/3 mL injection, to improve glycemic control in patients aged 10 years and older with type 2 diabetes.
Tirzepatide, the main ingredient in Mounjaro and Zepbound, is no longer in shortage, according to the U.S. Food and Drug ...
23, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug ... diabetes, and 90% to 95% of those individuals have type 2 diabetes. The prescribing information for the generic liraglutide injection ...